Search research articles
Contact Us
Filters
Showing results (181-190 of 197) with videos related to
Page
of 20
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
October 5, 2018
Results of a multicentre randomised controlled trial of cochlear-sparing intensity-modulated radiotherapy versus conventional radiotherapy in patients with parotid cancer (COSTAR; CRUK/08/004)
Christopher M Nutting, James P Morden, Matthew Beasley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 28, 2015
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
Robert H I Andtbacka, Howard L Kaufman, Frances Collichio, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 18, 2020
Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus Statement
David J Thomson, David Palma, Matthias Guckenberger, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 31, 2020
Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: An ASTRO-ESTRO consensus statement
David J Thomson, David Palma, Matthias Guckenberger, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 4, 2026
Lenvatinib plus pembrolizumab versus standard of care in recurrent/metastatic head and neck squamous cell carcinoma: Randomized, phase 2 LEAP-009 trial
Hye Ryun Kim, Marc Oliva, Sebastien Salas, et al.
International Journal of Cancer
|
April 30, 2024
The use of pembrolizumab monotherapy for the management of head and neck squamous cell carcinoma (HNSCC) in the UK
Ifigenia Vasiliadou, Derek Grose, Christina Wilson, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 28, 2014
Clinical trial designs for rare diseases: studies developed and discussed by the International Rare Cancers Initiative
Jan Bogaerts, Matthew R Sydes, Nicola Keat, et al.
Journal of the National Cancer Institute
|
August 9, 2022
Transoral Robotic Surgery for Recurrent Tumors of the Upper Aerodigestive Tract (RECUT): An International Cohort Study
John C Hardman, F Chris Holsinger, Grainne C Brady, et al.
Immunity
|
May 24, 2024
A RIPK1-specific PROTAC degrader achieves potent antitumor activity by enhancing immunogenic cell death
Jonathan Mannion, Valentina Gifford, Benjamin Bellenie, et al.
Oncoimmunology
|
June 26, 2023
Updates on radiotherapy-immunotherapy combinations: Proceedings of 6<sup>th</sup> annual ImmunoRad conference
Fabiana Gregucci, Sheila Spada, Mary Helen Barcellos-Hoff, et al.
Page
of 20
Search research articles
Search
Showing results (181-190 of 197) with videos related to
Sort By:
Page
of 20
European Journal of Cancer (Oxford, England : 1990)
|
October 5, 2018
Results of a multicentre randomised controlled trial of cochlear-sparing intensity-modulated radiotherapy versus conventional radiotherapy in patients with parotid cancer (COSTAR; CRUK/08/004)
Christopher M Nutting, James P Morden, Matthew Beasley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 28, 2015
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
Robert H I Andtbacka, Howard L Kaufman, Frances Collichio, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 18, 2020
Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus Statement
David J Thomson, David Palma, Matthias Guckenberger, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 31, 2020
Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: An ASTRO-ESTRO consensus statement
David J Thomson, David Palma, Matthias Guckenberger, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 4, 2026
Lenvatinib plus pembrolizumab versus standard of care in recurrent/metastatic head and neck squamous cell carcinoma: Randomized, phase 2 LEAP-009 trial
Hye Ryun Kim, Marc Oliva, Sebastien Salas, et al.
International Journal of Cancer
|
April 30, 2024
The use of pembrolizumab monotherapy for the management of head and neck squamous cell carcinoma (HNSCC) in the UK
Ifigenia Vasiliadou, Derek Grose, Christina Wilson, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 28, 2014
Clinical trial designs for rare diseases: studies developed and discussed by the International Rare Cancers Initiative
Jan Bogaerts, Matthew R Sydes, Nicola Keat, et al.
Journal of the National Cancer Institute
|
August 9, 2022
Transoral Robotic Surgery for Recurrent Tumors of the Upper Aerodigestive Tract (RECUT): An International Cohort Study
John C Hardman, F Chris Holsinger, Grainne C Brady, et al.
Immunity
|
May 24, 2024
A RIPK1-specific PROTAC degrader achieves potent antitumor activity by enhancing immunogenic cell death
Jonathan Mannion, Valentina Gifford, Benjamin Bellenie, et al.
Oncoimmunology
|
June 26, 2023
Updates on radiotherapy-immunotherapy combinations: Proceedings of 6<sup>th</sup> annual ImmunoRad conference
Fabiana Gregucci, Sheila Spada, Mary Helen Barcellos-Hoff, et al.
Page
of 20